Evidence map›Paper›PMID 26331842›Full record

ArticlePloS one2015

Molecular Dynamics Simulation Reveals the Selective Binding of Human Leukocyte Antigen Alleles Associated with Behçet's Disease.

Sirilak Kongkaew, Pathumwadee Yotmanee, Thanyada Rungrotmongkol, Nopporn Kaiyawet, Arthitaya Meeprasert, Toshikatsu Kaburaki, Hiroshi Noguchi, Fujio Takeuchi, Nawee Kungwan, Supot Hannongbua

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Heliyon · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Recent Developments and Applications of the MMPBSA Method.Frontiers in molecular biosciences · 2017
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Sirilak KongkaewProgram in Biotechnology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
Pathumwadee YotmaneeDepartment of Chemistry, Faculty of Science, Ramkhamhaeng University, Bangkok, Thailand.
Thanyada RungrotmongkolDepartment of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand; Ph.D. Program in Bioinformatics and Computational Biology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
Nopporn KaiyawetComputational Chemistry Unit Cell, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
Arthitaya MeeprasertDepartment of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
Toshikatsu KaburakiDepartment of Ophthalmology, University of Tokyo, Tokyo, Japan.
Hiroshi NoguchiSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Fujio TakeuchiDepartment of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo, Japan.
Nawee KungwanDepartment of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.
Supot HannongbuaComputational Chemistry Unit Cell, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
Chulalongkorn University · THThe University of Tokyo · JPChiang Mai University · THRamkhamhaeng University · THUniversity of Shizuoka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Behçet's disease (BD), a multi-organ inflammatory disorder, is associated with the presence of the human leukocyte antigen (HLA) HLA-B*51 allele in many ethnic groups. The possible antigen involvement of the major histocompatibility complex class I chain related gene A transmembrane (MICA-TM) nonapeptide (AAAAAIFVI) has been reported in BD symptomatic patients. This peptide has also been detected in HLA-A*26:01 positive patients. To investigate the link of BD with these two specific HLA alleles, molecular dynamics (MD) simulations were applied on the MICA-TM nonapeptide binding to the two BD-associated HLA alleles in comparison with the two non-BD-associated HLA alleles (B*35:01 and A*11:01). The MD simulations were applied on the four HLA/MICA-TM peptide complexes in aqueous solution. As a result, stabilization for the incoming MICA-TM was found to be predominantly contributed from van der Waals interactions. The P2/P3 residue close to the N-terminal and the P9 residue at the C-terminal of the MICA-TM nonapeptide served as the anchor for the peptide accommodated at the binding groove of the BD associated HLAs. The MM/PBSA free energy calculation predicted a stronger binding of the HLA/peptide complexes for the BD-associated HLA alleles than for the non-BD-associated ones, with a ranked binding strength of B*51:01 > B*35:01 and A*26:01 > A*11:01. Thus, the HLAs associated with BD pathogenesis expose the binding efficiency with the MICA-TM nonapeptide tighter than the non-associated HLA alleles. In addition, the residues 70, 73, 99, 146, 147 and 159 of the two BD-associated HLAs provided the conserved interaction for the MICA-TM peptide binding.

Indexed as

AllelesAmino Acid SequenceBehcet SyndromeHistocompatibility Antigens Class IHLA-A AntigensHLA-B51 AntigenHumansMolecular Dynamics SimulationHistocompatibility Antigens Class IHLA-A*26:01 antigenHLA-A AntigensHLA-B51 AntigenMHC class I-related chain A

Identifiers

PMID26331842
PMCPMC4557978
OpenAlexW1892103387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.